Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMC 1273874)

Published in Infect Immun on November 01, 2005

Authors

Chantal A A van der Graaf1, Mihai G Netea, Ineke Verschueren, Jos W M van der Meer, Bart Jan Kullberg

Author Affiliations

1: Department of Medicine (541), Radboud University Nijmegen Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.

Articles citing this

Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol (2011) 2.70

Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog (2008) 2.14

The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol (2006) 1.94

Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation. Immunity (2015) 1.69

Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect Immun (2008) 1.26

The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol (2011) 1.22

Immune defence against Candida fungal infections. Nat Rev Immunol (2015) 1.19

MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J Immunol (2008) 1.19

Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun (2007) 1.16

Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc Natl Acad Sci U S A (2014) 1.10

Growth of Candida albicans cells on the physiologically relevant carbon source lactate affects their recognition and phagocytosis by immune cells. Infect Immun (2012) 1.06

Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med (2011) 1.05

Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. FEMS Yeast Res (2009) 1.04

Epithelial GM-CSF induction by Candida glabrata. J Dent Res (2009) 0.98

A murine model of contact lens-associated fusarium keratitis. Invest Ophthalmol Vis Sci (2009) 0.98

IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans. J Immunol (2015) 0.97

Candida and invasive candidiasis: back to basics. Eur J Clin Microbiol Infect Dis (2011) 0.97

Interactions of fungal pathogens with phagocytes. Nat Rev Microbiol (2016) 0.96

Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis. Expert Rev Mol Med (2008) 0.93

Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis. J Acquir Immune Defic Syndr (2010) 0.90

The early transcriptional response of human granulocytes to infection with Candida albicans is not essential for killing but reflects cellular communications. Infect Immun (2006) 0.89

Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infect Immun (2010) 0.88

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease. MBio (2016) 0.87

Bmh1p (14-3-3) mediates pathways associated with virulence in Candida albicans. Microbiology (2009) 0.86

Proinflammatory chemokines during Candida albicans keratitis. Exp Eye Res (2009) 0.84

Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency. Clin Exp Immunol (2009) 0.84

Escherichia coli and TNF-alpha modulate macrophage phagocytosis of Candida glabrata. J Surg Res (2008) 0.82

An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism. Cytokine (2014) 0.82

Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action. Med Mycol (2012) 0.82

Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. Front Microbiol (2015) 0.80

Candida albicans releases soluble factors that potentiate cytokine production by human cells through a protease-activated receptor 1- and 2-independent pathway. Infect Immun (2009) 0.78

Candida albicans increases tumor cell adhesion to endothelial cells in vitro: intraspecific differences and importance of the mannose receptor. PLoS One (2013) 0.77

Systems Level Dissection of Candida Recognition by Dectins: A Matter of Fungal Morphology and Site of Infection. Pathogens (2015) 0.76

Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine. Sci Rep (2016) 0.75

Candida albicans Yeast, Pseudohyphal, and Hyphal Morphogenesis Differentially Affects Immune Recognition. Front Immunol (2017) 0.75

Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species. Cytokine (2015) 0.75

Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum. Sci Rep (2016) 0.75

Cooperative Evolutionary Strategy between the Bacteriome and Mycobiome. MBio (2016) 0.75

Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis. Clin Vaccine Immunol (2006) 0.75

Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination. Gut Pathog (2017) 0.75

An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility. PLoS One (2017) 0.75

Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis. PLoS Pathog (2017) 0.75

Articles cited by this

Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80

Toll-like receptors in the induction of the innate immune response. Nature (2000) 12.23

Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med (2003) 7.38

Dectin-1 mediates the biological effects of beta-glucans. J Exp Med (2003) 5.82

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol (2003) 4.31

The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis (2002) 3.46

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol (2004) 3.13

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem (2003) 3.13

Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med (2000) 2.99

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest (1996) 2.03

Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis (2003) 1.91

Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis (2003) 1.91

Epidemiology of opportunistic invasive mycoses. Eur J Med Res (2002) 1.86

Candida albicans septin mutants are defective for invasive growth and virulence. Infect Immun (2003) 1.58

Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol (2002) 1.57

Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol (1999) 1.57

Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect (2004) 1.40

Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis (1993) 1.29

Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect Immun (1999) 1.24

Deletion of the NOT4 gene impairs hyphal development and pathogenicity in Candida albicans. Microbiology (2004) 1.15

Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection. Eur J Immunol (2003) 1.07

Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J Infect Dis (1998) 1.00

Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans. Infect Immun (2000) 0.99

gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans. Infect Immun (1996) 0.91

Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: inhibitory role of C. albicans germination. Infect Immun (2001) 0.87

Articles by these authors

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis (2008) 20.88

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

How should we define health? BMJ (2011) 7.82

Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis (2012) 5.83

Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med (2009) 5.27

An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol (2008) 5.13

Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest (2006) 4.72

Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood (2008) 4.63

Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest (2006) 4.45

Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ (2010) 4.44

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40

Invasive Candidiasis. N Engl J Med (2015) 4.18

Chronic fatigue syndrome. Lancet (2006) 4.15

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A (2012) 3.62

The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis (2002) 3.46

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis (2007) 3.15

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol (2004) 3.13

The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab (2010) 3.11

STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med (2011) 3.11

The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe (2009) 3.07

Trained immunity: a memory for innate host defense. Cell Host Microbe (2011) 2.94

Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 2.92

Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut (2011) 2.91

IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A (2014) 2.86

Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med (2006) 2.86

Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79

Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol (2011) 2.75

Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain (2008) 2.75

Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol (2011) 2.70

IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A (2006) 2.67

Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med (2013) 2.65

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol (2008) 2.62

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol (2005) 2.52

Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis (2009) 2.49

Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum (2007) 2.42

Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A (2010) 2.38

Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum (2007) 2.32

The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur J Immunol (2003) 2.30

Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol (2009) 2.28

TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A (2007) 2.28

Immune recognition of Candida albicans beta-glucan by dectin-1. J Infect Dis (2007) 2.24

Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum (2009) 2.23

Planning the human variome project: the Spain report. Hum Mutat (2009) 2.22

Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med (2007) 2.18

The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res (2007) 2.15

Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis (2010) 2.12

Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol (2008) 2.11

NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog (2005) 2.04

CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J Clin Invest (2013) 2.00

A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat Immunol (2009) 2.00

Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis (2003) 1.91

Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol (2011) 1.90

NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol (2004) 1.90

Possible detrimental effects of cognitive behaviour therapy for chronic fatigue syndrome. Psychother Psychosom (2010) 1.89

A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore) (2007) 1.87

Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. J Infect Dis (2006) 1.78

Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol (2006) 1.77

The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol (2011) 1.76

Functional consequences of toll-like receptor 4 polymorphisms. Mol Med (2008) 1.76

Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) (2008) 1.74

Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol (2002) 1.72

Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet (2010) 1.71

Proinflammatory cytokines and sepsis syndrome: not enough, or too much of a good thing? Trends Immunol (2003) 1.70

A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr (2002) 1.67

A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol (2013) 1.67

Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial. Clin Infect Dis (2007) 1.65

Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. J Immunol (2007) 1.63

Interplay between Candida albicans and the mammalian innate host defense. Infect Immun (2012) 1.62

Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun (2006) 1.62

Mechanical ventilation induces a Toll/interleukin-1 receptor domain-containing adapter-inducing interferon beta-dependent inflammatory response in healthy mice. Anesthesiology (2009) 1.61

99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation. J Nucl Med (2007) 1.61